SMARTFLEX ALSO MEMBER OF THE IOMG FAMILY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : SMARTFLEX ALSO MEMBER OF THE IOMG FAMILY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kent Sarikaya who wrote (388)	8/10/1997 11:39:00 AM
From: Joe Dancy	of 558

Kent - I found the article by mistake - I ran my screens again yesterday to find companies that are cheap with growth potential. Three familiar ECM companies turned up - SFLX (growth estimate of 20% yr and trailing PE of 13.1), ELAMEX (ELAMF) (growth estimate of 20% yr and trailing PE of 10.6), and Nam Tai Electronics (NTAIF)(growth estimate of 20% yr and trailing PE of 10.8). Looking up Nam Tai I ran across the article which noted their explosive last quarter - I think SFLX has the same potential, maybe not this quarter but some quarter relatively soon. I have looked at ELAMEX and Nam Tai, and traded notes with Paul and others on them, but decided to stay closer to home with SFLX - ELAMEX is Mexico based and Nam Tai Hong Kong based. I figure small caps are explosive enough without worrying about the foreign risks involved - and the fact that even if they grow there may still be a lack of analyst and institutional coverage and interest - when institutions get interested it can drive the price of better known companies. One foreign (U.K.) company that got listed on the NASDAQ then found how hard it was to get U.S. institutions interested in the exciting technolgy they're developing is a drug delivery company called Ethical Holdings (ETHCY) - about as far away from ECMs as you can get. They have finally thrown in the towel and hired Lehman Brothers to sell or merge the company even though their drugs in their pipeline, on the market, their technology, licenses and joint technology agreements have been quite impressive since they went public in 1993. Problem is most of the agreements and approvals and drugs are marketed outside the U.S. Share price has gone down on positive news - seems no matter what they do no institutions are interested, partly because its so small (market cap $65 million). My take is at members.aol.com and I've been buying lately along with more SFLX which I consider a steal at the current market price for long term holders. In any event, based on my screens SFLX remains a strong buy, and the ELAMEX and Nam Tai ECM fans should do well also if you can believe the numbers. Best - Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next